Aggrastat is a cardiovascular drug used to treat acute coronary syndrome (ACS). It is a type of antiplatelet drug, which works by preventing the formation of blood clots in the arteries. It is used to reduce the risk of death and heart attack in patients with ACS. Aggrastat is also used to reduce the risk of stroke in patients with atrial fibrillation. It is usually taken in combination with other medications, such as aspirin and clopidogrel.
Aggrastat is a widely used drug in the cardiovascular market, and is available in both generic and branded forms. It is typically prescribed by cardiologists and other healthcare professionals. The drug is available in both oral and intravenous forms, and is typically administered in a hospital setting.
Some companies in the Aggrastat market include AstraZeneca, Bristol-Myers Squibb, Merck, Pfizer, and Sanofi. Show Less Read more
